NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹169 Cr | ₹225 Cr | ₹134 Cr | ₹95 Cr | ₹21 Cr |
What is the latest Cash Flow from Operating Activities ratio of NECTAR LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹169 Cr |
| Mar2024 | ₹225 Cr |
| Mar2023 | ₹134 Cr |
| Mar2022 | ₹95 Cr |
| Mar2021 | ₹21 Cr |
How is Cash Flow from Operating Activities of NECTAR LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹169 Cr | -24.59 | |
| Mar2024 | ₹225 Cr | 68.11 | |
| Mar2023 | ₹134 Cr | 40.68 | |
| Mar2022 | ₹95 Cr | 344.38 | |
| Mar2021 | ₹21 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹224.8 Cr | -0.7% | -3.4% | -46.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.7% |
-3.4% |
-46.4% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses